Leading plant-based Arkopharma is the European leader in plant-based medicine and nutritional supplements with an international footprint in over 60 countries, indicating a broad distribution network and potential for cross-border partnerships and private-label opportunities.

Healthcare professional focus The company emphasizes providing natural medicines for treatment and prevention and offers healthcare professionals new options for advice and prescriptions, suggesting sales potential in medical channels, clinics, pharmacies, and B2B collaborations with practitioners.

Productivity and scale With 1501 employees and consolidated sales around 201.3 million euros, Arkopharma demonstrates substantial production capacity and commercial reach, enabling scalable partnerships, large-volume orders, and co-development of new plant-based formulations.

R&D commitment Allocating 3 percent of sales to R&D and maintaining a robust pipeline of medicines (over 1,800 registrations and MA approvals) signals ongoing innovation potential and opportunities for new product launches and regulatory-driven growth.

Sustainability and values Strong commitments to diversity, equality, and safe working conditions align with responsible sourcing and ESG-focused partnerships, which can be leveraged to attract sustainability-minded customers, distributors, and retailers seeking compliant supply chains.